Global /United States /Healthcare /Diagnostics & Research /ENZB
chevron_leftBack
Enzo Biochem, Inc. logo

Enzo Biochem, Inc.

ENZB
OTCMKTS: ENZB Delayed
0.6989USD 1.7%
As of 18 June 2026, Enzo Biochem, Inc. has a market cap of $36.59M USD, ranking #32893 globally and #4663 in the United States. It ranks #2970 in the Healthcare sector, and #8 in the Diagnostics & Research industry.
Global Rank
32893
Country Rank
4663
Sector Rank
2970
Industry Rank
8
Key Stats
Market Cap
$36.59MUSD
Enterprise Value
$2.9MUSD
Revenue (TTM)
$27.47MUSD
EBITDA (TTM)
-$9.93MUSD
Net Income (TTM)
-$21.08MUSD
EBITDA Margin
-36%
Profit Margin
-77%
PS Ratio
1.3
PB Ratio
0.8
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Diagnostics & Research
CEO
Kara Cannon open_in_new
Employees
136
Founded
1976
Website
enzo.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
1.7% 1.2% 2.5% 25% 39% -38%

News

Loading...

Markets

Exchange Ticker Price
OTC Markets
MIC: OTCM
PRIMARY
ENZB
Enzo Biochem Inc
ISIN: US2941001024
Shares Out.:
52.353M1 Shares Float: 28.765M2
TV:
SA:
YF:
GF:
BA:
MS:
0.6989 USD
London Stock Exchange
MIC: XLON
0IHV
Enzo Biochem Inc
ISIN: US2941001024
TV:
SA:
YF:
GF:
BA:
MS:
0.6849 USD
NYSE
MIC: XNYS
ENZ
Enzo Biochem Inc
ISIN: US2941001024
TV:
SA:
YF:
ENZ
GF:
NQ:
ENZ
BA:
ENZ
MS:
0.3360 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Enzo Biochem, Inc.

Enzo Biochem, Inc., a life sciences company, engages in the labeling and detection technologies from DNA to whole cell analysis in the United States and internationally. The company offers labels, dyes, antibodies, genomic probes, immunoassays, biochemicals, and proteins are used to label, detect, and visualize a biological target of interest in drug discovery exploration and drug development process development. Its proprietary products and technologies play roles in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. The company licenses its technology. It serves academic researchers, clinical researchers, biotechnology and pharmaceutical companies, and diagnostic manufacturers. Enzo Biochem, Inc. was incorporated in 1976 and is headquartered in Farmingdale, New York.

Similar Companies

Industry: Diagnostics & Research (United States)
Name
Market Cap diff.
PE
$20.96B
57K%
20.9
EXAS
$20.03B
55K%
-
MEHCQ
$96.4M
163%
-
PMDI
$13.46M
-63%
-
$6.89M
-81%
-
APDN
$2.9M
-92%
-
Industry: Diagnostics & Research (Global)
Name
Market Cap diff.
PE
Q
QIA
$8.5B
7.3B EUR
23K%
20.2
CORBF
$73.65M
101%
0.8
$46.04M
7.39B JPY
26%
-
$43.38M
2.17B EGP
19%
-
246250
$17.63M
26.89B KRW
-52%
-
LDDD
$15.31M
-58%
-
chevron_leftBack